1. Home
  2. DPRO vs DERM Comparison

DPRO vs DERM Comparison

Compare DPRO & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Draganfly Inc.

DPRO

Draganfly Inc.

HOLD

Current Price

$6.64

Market Cap

230.7M

Sector

Industrials

ML Signal

HOLD

Logo Journey Medical Corporation

DERM

Journey Medical Corporation

HOLD

Current Price

$7.13

Market Cap

267.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DPRO
DERM
Founded
1998
2014
Country
Canada
United States
Employees
N/A
N/A
Industry
Aerospace
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
230.7M
267.4M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
DPRO
DERM
Price
$6.64
$7.13
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$15.67
$12.67
AVG Volume (30 Days)
1.9M
94.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$56,134,000.00
Revenue This Year
$42.16
$17.48
Revenue Next Year
$145.52
$55.83
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.63
$5.40
52 Week High
$14.37
$9.56

Technical Indicators

Market Signals
Indicator
DPRO
DERM
Relative Strength Index (RSI) 46.34 36.56
Support Level $6.23 $6.77
Resistance Level $7.15 $8.02
Average True Range (ATR) 0.50 0.49
MACD 0.03 -0.09
Stochastic Oscillator 40.92 8.43

Price Performance

Historical Comparison
DPRO
DERM

About DPRO Draganfly Inc.

Draganfly Inc is a Canada based company. It is engaged in the provision of engineering services and the manufacture of commercial unmanned vehicle systems and software. The company operates in Canada, the United States, and Internationally. The three segments are Drones, Vital (Vital Intelligence), and Corporate. The Drones segment derives its revenue from products and services related to the sale of unmanned aerial vehicles (UAV). The Vital segment derives its revenue from the sale of products that measure vitals to help detect symptoms from large groups of people from a distance. The Corporate segment includes all costs not directly associated with the Drone and Vital segments. It generates majority of its revenue from Drones segment.

About DERM Journey Medical Corporation

Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.

Share on Social Networks: